International Pharma GMP and DMF Registration Compliance Guide
In-depth guide to CEP/US DMF compilation, WHO APIMF registration, GMP gap analysis, FDA 483 observations response, and CAPA closure support for global market access.
The core of global pharmaceutical compliance lies in establishing a GxP quality system aligned with ICH guidelines and regulatory bodies (FDA, EMA) while advancing DMF/CEP filings. Upon receiving an inspection report (such as FDA 483 or Warning Letter), a professional response based on root cause analysis and CAPA must be submitted within 15 business days.
Drug Master File (DMF/MF) compilation & filing
A Drug Master File (DMF) is the core technical documentation for APIs or intermediates entering global markets. We compile CTD format files per ICH M4 guidelines, including US DMF, CEP, EDMF, and Japan MF. Support covers Module 3 manufacturing studies, quality control, stability testing, impurity profiling, deficiency responses, and annual updates.
- Compilation of US DMF, CEP, EDMF, Japan MF dossiers
- CTD Module 3 compilation with stability and impurity files
- Change control, annual reports, and regulatory response support
WHO APIMF & API Prequalification
For API suppliers aiming for the WHO procurement system, WHO Prequalification is the entry ticket. We provide WHO APIMF filing, prequalification application coaching, and hands-on consulting for WHO site inspections and response coordination.
- WHO APIMF application compilation and filing
- API Prequalification program consulting and support
- Communication coordination for WHO site audits
GMP gap analysis and inspection readiness
Before FDA inspection, pre-approval inspection (PAI), or WHO PQ site audit, readiness review helps teams identify systemic gaps early. Gap analysis evaluates facility layout, HVAC validation, pressure differentials, process and analytical validation, batch records, data integrity, quality agreements, and staff operations to reduce deficiency risk.
- FDA inspection & PAI readiness review
- Facilities, cleanroom, HVAC, and utility validation check
- Data Integrity (DI) & CSV gap assessments
FDA 483 & Warning Letter response (CAPA)
When a site receives FDA 483 observations or Warning Letters, a response detailing root cause analysis and CAPA must be submitted within 15 business days. A professional CAPA plan should combine short-term corrections and long-term systemic remediation, backed by editable SOPs, training logs, and validation evidence. QTC experts help close out CAPA findings and draft official responses.
- FDA 483 & Warning Letter Root Cause Analysis
- CAPA plan drafting and remediation coaching
- Response Letter drafting within 15 business days
Translation & professional interpretation
International on-site regulatory inspections require highly professional translation. Our team has life sciences backgrounds, well-versed in GMP inspection dynamics, audit style, and terminology. We provide professional translation for Quality Manuals, SOPs, deviations, validation protocols, and response reports to ensure alignment with regulatory standards.
- Interpretation: FDA, EMA, WHO inspection accompaniment
- Translation: Quality manuals, SOPs, validation, deviation reports
- Readiness training: management and site staff Q&A simulation
FAQ
How long does it take to compile a US DMF?+
Typically 3 to 6 months depending on synthesis route complexity, available quality data, and analytical validation completeness. We recommend starting the project 12 months before targeting product delivery to formulation customers.
How should we handle an FDA 483 observation report?+
A detailed response must be submitted to the FDA within 15 business days. The response must explain root cause analysis for each observation, short-term corrective actions, CAPAs, and supporting evidence. We recommend engaging third-party experts immediately to prevent escalation.
Do QTC interpreters have pharmaceutical backgrounds?+
Yes. Interpreters for official audits (FDA/EMA/WHO) have pharmacy, biochemistry, or life sciences education and GxP experience to support precise communication during QA sessions, deviation walkthroughs, and cleanroom tours.
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
